Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-035/16
A61K-038/19
A61K-038/22
A61L-027/36
A61K-038/18
A61K-038/37
출원번호
US-0792691
(2013-03-11)
등록번호
US-8911789
(2014-12-16)
발명자
/ 주소
Campbell, Phil G.
Burgess, James E.
Weiss, Lee E.
Smith, Jason
출원인 / 주소
Carnegie Mellon University
대리인 / 주소
Fish & Richardson P.C.
인용정보
피인용 횟수 :
1인용 특허 :
127
초록▼
Blood-derived plastic articles prepared from compositions including blood and, in some embodiments, at least one crosslinking agent and/or at least one biological response modifier, that can be useful for biological applications such as wound repair and tissue grafts; methods of making and using the
Blood-derived plastic articles prepared from compositions including blood and, in some embodiments, at least one crosslinking agent and/or at least one biological response modifier, that can be useful for biological applications such as wound repair and tissue grafts; methods of making and using the same; methods for assessing the concentration of a biological response modifier in an article; and systems for preparing blood-derived plastic articles are provided.
대표청구항▼
1. A blood-derived plastic article comprising at least partially dried and clotted whole plasma, at least one biological response modifier, and at least one drug selected from the group consisting of an antibiotic, an analgesic, an anti-inflammatory, an immunosuppressive, an immunomodulator, and mix
1. A blood-derived plastic article comprising at least partially dried and clotted whole plasma, at least one biological response modifier, and at least one drug selected from the group consisting of an antibiotic, an analgesic, an anti-inflammatory, an immunosuppressive, an immunomodulator, and mixtures thereof. 2. The blood-derived plastic article according to claim 1, wherein the at least one drug is an antibiotic. 3. The blood-derived plastic article according to claim 2, wherein the antibiotic is a heat sensitive antibiotic. 4. The blood-derived plastic article according to claim 2, wherein the antibiotic is selected from the group consisting of cephalosporins, penicillins, sulfonamides, and tetracyclines. 5. The blood-derived plastic article according to claim 2, wherein the antibiotic is an aminoglycoside antibiotic. 6. The blood-derived plastic article according to claim 5, wherein the aminoglycoside antibiotic is selected from the group consisting of gentamicin and neomycin. 7. The blood-derived plastic article according to claim 2, wherein the antibiotic is a glycopeptide antibiotic. 8. The blood-derived plastic article according to claim 7, wherein the glycopeptide antibiotic is vancomycin. 9. The blood-derived plastic article according to claim 2, wherein the antibiotic is a macrolide antibiotic. 10. The blood-derived plastic article according to claim 9, wherein the macrolide antibiotic is selected from the group consisting of azithromycin and clarithromycin. 11. The blood-derived plastic article according to claim 2, wherein the antibiotic is a quinolone antibiotic. 12. The blood-derived plastic article according to claim 11, wherein the quinolone antibiotic is selected from the group consisting of ciprofloxacin, gatifloxacin, and levofloxacin. 13. The blood-derived plastic article according to claim 2, wherein the antibiotic is present in the blood-derived plastic article in a concentration gradient. 14. The blood-derived plastic article according to claim 1, wherein the at least one drug is a steroidal anti-inflammatory. 15. The blood-derived plastic article according to claim 1, wherein the blood-derived plastic article comprises at least two drugs, wherein at least one drug is an antibiotic and at least one drug is an analgesic. 16. The blood-derived plastic article according to claim 15, wherein the blood-derived plastic article comprises an antibiotic and an analgesic. 17. The blood-derived plastic article according to claim 15, wherein the antibiotic and the analgesic are present in the blood-derived plastic article in a concentration gradient. 18. The blood-derived plastic article according to claim 1, wherein the blood-derived plastic article comprises at least three drugs, wherein at least one drug is an antibiotic, at least one drug is an anti-inflammatory, and at least one drug is an analgesic. 19. The blood-derived plastic article according to claim 18, wherein the blood-derived plastic article comprises an antibiotic, an anti-inflammatory, and an analgesic. 20. The blood-derived plastic article according to claim 18, wherein the anti-inflammatory is present in the blood-derived plastic article in a concentration gradient. 21. The blood-derived plastic article according to claim 18, wherein the analgesic is present in the blood-derived plastic article in a concentration gradient. 22. The blood-derived plastic article according to claim 18, wherein the antibiotic, anti-inflammatory, and analgesic are present in the blood-derived article in a concentration gradient. 23. The blood-derived plastic article according to claim 1, wherein the at least one drug is lidocaine. 24. The blood-derived plastic article according to claim 1, comprising a concentration gradient of the at least one drug. 25. The blood-derived plastic article according to claim 1, wherein the at least one biological response modifier is present in the blood-derived article in a concentration gradient. 26. The blood-derived plastic article according to claim 1, wherein the at least one biological response modifier and the at least one drug are present in the blood-derived article in a concentration gradient. 27. The blood-derived plastic article according to claim 1, wherein the article is in the form of a film, patch, powder, putty, or solid block. 28. The blood-derived plastic article according to claim 1, wherein the at least one biological response modifier is a bioactive protein selected from the group consisting of hormones, growth factors, cytokines, extracellular matrix molecules, and mixtures thereof. 29. The blood-derived plastic article according to claim 28, wherein the bioactive protein comprises at least one growth factor selected from the group consisting of platelet derived growth factors (PDGF), acidic and basic fibroblast growth factors, transformation growth factor beta (TGF-beta), insulin like growth factors (IGF), epidermal growth factors (EGF), platelet-derived angiogenesis factors (PDAF), platelet-derived endothelial growth factors (PDEGF), tumor necrosis factor-alpha (TNF-α), tumor necrosis factor-beta (TNF-β), vascular endothelial growth factors (VEGF), epithelial cell growth factors (ECGF), granulocyte-colony stimulating factors (G-C SF), granulocyte-macrophage colony stimulating factors (GM-CSF), nerve growth factors (NGF), neurotrophins, erythropoietin (EPO), thrombopoietin (TPO), myostatin (GDF-8), growth differentiation factor-9 (GDF9), hepatocyte growth factors (HGF), platelet factors, and mixtures thereof. 30. The blood-derived plastic article according to claim 28, wherein the bioactive protein comprises at least one extracellular matrix molecule selected from the group consisting of osteocalcin, osteonectin, fibrinogen, vitronectin, fibronectin, thrombospondin 1 (TSP-1), bone sialoprotein (BSP), proteoglycans, and mixtures thereof. 31. The blood-derived plastic article of claim 1, wherein the platelet concentration of the whole plasma in the blood-derived plastic article is increased compared to a baseline platelet concentration of whole plasma. 32. The blood-derived plastic article according to claim 1, wherein the blood-derived plastic article further comprises at least one plasticizer. 33. The blood-derived plastic article according to claim 32, wherein the at least one plasticizer is selected from water and glycerol. 34. The blood-derived plastic article according to claim 33, wherein the at least one plasticizer is glycerol. 35. The blood-derived plastic article according to claim 32, wherein the at least one plasticizer is present in an amount of about 0.1 to about 80 percent by weight of the blood-derived plastic article. 36. The blood-derived plastic article according to claim 1, wherein the blood-derived plastic article further comprises at least one crosslinking agent. 37. The blood-derived plastic article according to claim 36, wherein the at least one crosslinking agent is genipin. 38. The blood-derived plastic article according to claim 37, wherein the at least one crosslinking agent is present in an amount of about 0.01 to about 20 percent by weight of the blood-derived plastic article. 39. A blood-derived plastic article comprising at least partially dried and clotted whole plasma, at least one biological response modifier, and at least one antibiotic. 40. The blood-derived plastic article of claim 39, wherein the at least one antibiotic is selected from the group consisting of an aminoglycoside antibiotic and a glycopeptide antibiotic. 41. The blood-derived plastic article according to claim 40, wherein the aminoglycoside antibiotic is selected from the group consisting of gentamicin and neomycin. 42. The blood-derived plastic article according to claim 40, wherein the glycopeptide antibiotic is vancomycin. 43. The blood-derived plastic article according to claim 39, wherein the at least one biological response modifier is a bioactive protein selected from the group consisting of hormones, growth factors, cytokines, extracellular matrix molecules, and mixtures thereof. 44. The blood-derived plastic article according to claim 43, wherein the bioactive protein comprises at least one growth factor selected from the group consisting of platelet derived growth factors (PDGF), acidic and basic fibroblast growth factors, transformation growth factor beta (TGF-beta), insulin like growth factors (IGF), epidermal growth factors (EGF), platelet-derived angiogenesis factors (PDAF), platelet-derived endothelial growth factors (PDEGF), tumor necrosis factor-alpha (TNF-α), tumor necrosis factor-beta (TNF-β), vascular endothelial growth factors (VEGF), epithelial cell growth factors (ECGF), granulocyte-colony stimulating factors (G-CSF), granulocyte-macrophage colony stimulating factors (GM-CSF), nerve growth factors (NGF), neurotrophins, erythropoietin (EPO), thrombopoietin (TPO), myostatin (GDF-8), growth differentiation factor-9 (GDF9), hepatocyte growth factors (HGF), platelet factors, and mixtures thereof. 45. The blood-derived plastic article according to claim 43, wherein the bioactive protein comprises at least one extracellular matrix molecule selected from the group consisting of osteocalcin, osteonectin, fibrinogen, vitronectin, fibronectin, thrombospondin 1 (TSP-1), bone sialoprotein (BSP), proteoglycans, and mixtures thereof. 46. The blood-derived plastic article of claim 39, wherein the platelet concentration of the whole plasma in the blood-derived plastic article is increased compared to a baseline platelet concentration of whole plasma. 47. The blood-derived plastic article according to claim 39, wherein the blood-derived plastic article further comprises at least one plasticizer. 48. The blood-derived plastic article according to claim 47, wherein the at least one plasticizer is selected from water and glycerol. 49. The blood-derived plastic article according to claim 48, wherein the at least one plasticizer is glycerol. 50. The blood-derived plastic article according to claim 47, wherein the at least one plasticizer is present in an amount of about 0.1 to about 80 percent by weight of the blood-derived plastic article. 51. The blood-derived plastic article according to claim 39, wherein the blood-derived plastic article further comprises at least one crosslinking agent. 52. The blood-derived plastic article according to claim 51, wherein the at least one crosslinking agent is genipin. 53. The blood-derived plastic article according to claim 51, wherein the at least one crosslinking agent is present in an amount of about 0.01 to about 20 percent by weight of the blood-derived plastic article.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (127)
Van Dyke Mark E. ; Timmons Scott F. ; Blanchard Cheryl R. ; Siller-Jackson Arlene J. ; Smith Robert A., Absorbent keratin wound dressing.
Coelho,Philip Henry; Kingsley,Phil; Brausch,Jim; Godsey,James H.; Rock,Gail, Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby.
Prinz Fritz B. (5801 Northumberland St. Pittsburgh PA 15217) Weiss Lee E. (6558 Darlington Rd. Pittsburgh PA 15217), Automated system for forming objects by incremental buildup of layers.
Krezanoski Joseph Z. (Los Altos CA), Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery t.
Allcock Harry R. (State College PA) Neenan Thomas X. (State College PA) Kossa Walter C. (Wilkes-Barre PA), Coupling of polyorganophosphazenes to carboxylic acid.
MacLaughlin, David T.; Vacanti, Joseph P.; Donahoe, Patricia K.; Masiakos, Peter T., Delivery of therapeutic biologicals from implantable tissue matrices.
Edwards Stuart D. ; Wehman Thomas ; Parker Theodore L. ; Skalnyi Eugene V. ; Kucklick Theodore ; Evans John, Devices for sealing punctures in body vessels.
Badylak Stephen F. (W. Lafayette IN) Geddes Leslie A. (W. Lafayette IN) Shelbourne K. Donald (Indianapolis IN) Lantz Gary C. (Lafayette IN) Coffey Arthur C. (Indianapolis IN), Graft for promoting autogenous tissue growth.
Badylak Stephen F. (W. Lafayette IN) Geddes Leslie A. (W. Lafayette IN) Shelbourne K. Donald (Indianapolis IN) Lantz Gary C. (Lafayette IN) Coffey Arthur C. (Indianapolis IN), Graft for promoting autogenous tissue growth.
Badylak Stephen F. (W. Lafayette IN) Geddes Leslie A. (W. Lafayette IN) Shelbourne K. Donald (Indianapolis IN) Lantz Gary C. (Lafayette IN) Coffey Arthur C. (Indianapolis IN), Graft for promoting autogenous tissue growth.
Carr ; Jr. Marcus E. (Richmond VA), Instrumentation and method for evaluating platelet performance during clotting and dissolution of blood clots and for ev.
Patel Umesh H. ; Hiles Michael C. ; Whitson Bryan ; Cheng Boyle ; Badylak Stephen F. ; Kokini Klod, Large area submucosal tissue graft constructs and method for making the same.
Weiss Lee E. (6558 Darlington Rd. Pittsburgh PA 15217) Prinz Fritz R. (5801 Northumberland St. Pittsburgh PA 15217) Gursoz E. Levent (4232 Saline St. Pittsburgh PA 15217), Method and apparatus for fabrication of three-dimensional articles by thermal spray deposition.
Burgess, James E.; Campbell, Phil G.; Weiss, Lee E.; Smith, Jason, Method and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom.
Wang Yulun ; Uecker Darrin R. ; Jordan Charles S. ; Wright James W. ; Laby Keith Phillip ; Wilson Jeff D., Method and apparatus for performing minimally invasive cardiac procedures.
Prinz Fritz (6558 Darlington Rd. Pittsburgh PA 15217) Weiss Lee (5801 Northumberland St. Pittsburgh PA 15217), Method and support structures for creation of objects by layer deposition.
Prinz Fritz B. (5801 Northumberland St. Pittsburgh PA 15217) Weiss Lee E. (6558 Darlington Rd. Pittsburgh PA 15217), Method for fabrication of three-dimensional articles.
Hogan Michael E. (The Woodlands TX) Kessler Donald J. (The Woodlands TX), Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming.
Philip Henry Coelho ; Phil Kingsley ; Jim Brausch ; James H. Godsey ; Gail Rock CA; Trista K. Madsen ; Sona B. Frausto, Method for preparing thrombin for use in a biological glue.
Dinh Thomas Q. (5319 Baker Rd. Minnetonka MN) Tuch Ronald J. (12330 51st Ave. N. Plymouth MN) Dror Michael (6227 Westridge Blvd. Edina MN), Method of making an intraluminal stent.
Williams Stuart K. (Drexel Hill PA) Jarrell Bruce E. (Philadelphia PA), Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surfa.
Campbell, Phil G.; Burgess, James E.; Weiss, Lee E.; Smith, Jason, Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom.
Campbell, Phil G.; Burgess, James E.; Weiss, Lee E.; Smith, Jason, Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom.
Campbell, Phil G.; Burgess, James E.; Weiss, Lee E.; Smith, Jason, Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom.
Campbell, Phil G.; Burgess, James E.; Weiss, Lee E.; Smith, Jason, Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom.
Campbell, Phil G.; Burgess, James E.; Weiss, Lee E.; Smith, Jason, Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom.
Patel Umesh H. ; Hiles Michael C. ; Whitson Bryan A. ; Cheng Boyle ; Badylak Stephen F. ; Kokini Klod, Multilayered submucosal graft constructs and method for making the same.
Eppstein Deborah A. (Menlo Park CA) Felgner Philip L. (Los Altos CA) Gadek Thomas R. (Oakland CA) Jones Gordon H. (Cupertino CA) Roman Richard B. (Fairhope AL), N-(www
상세보기
Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
Haslam John L. (Lawrence KS) Higuchi Takeru (Lawrence KS) Mlodozeniec Arthur R. (Lawrence KS), Ophthalmic drug delivery system utilizing thermosetting gels.
Hubbell Jeffrey A. (Austin TX) Pathak Chandrashekhar P. (Waltham MA) Sawhney Amarpreet S. (Newton MA) Desai Neil P. (Los Angeles CA) Hill Jennifer L. (Austin TX), Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers.
Antanavich Richard D. (Paso Robles CA) Dorian Randel (Orinda CA), Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant.
Marchant Roger E. (Shaker Hts. OH), Process for producing hydroxylated plasma-polymerized films and the use of the films for enhancing the compatiblity of b.
Zimmermann Eberhard (Mnster-Nienberge DEX) Stroetmann Michael (Mnster DEX), Resorptive sheet material for closing and healing wounds and method of making the same.
Bernard Christopher J. ; Kang Hyosig ; Sachs Barton L. ; Singh Sunil K. ; Wen John T., Robotic system, docking station, and surgical tool for collaborative control in minimally invasive surgery.
Badylak Stephen F. (W. Lafayette IN) Boder George (Martinsville IN) Voytik Sherry (Lafayette IN) Demeter Robert J. (Mooresville IN) Critser John (Carmel IN) Liu Chi (Indianapolis IN), Submucosa as a growth substrate for islet cells.
MacPhee Martin James ; Drohan William Nash ; Woolverton Christoper J., Supplemented and unsupplemented tissue sealants, methods of their production and use.
Tierney Michael J. ; Cooper Thomas G. ; Julian Chris A. ; Blumenkranz Stephen J. ; Guthart Gary S. ; Younge Robert G., Surgical robotic tools, data architecture, and use.
Badylak Stephen F. (West Lafayette IN) Geddes Leslie A. (West Lafayette IN) Shelbourne K. Donald (Indianapolis IN) Lantz Gary C. (Lafayette IN) Coffey Arthur C. (Indianapolis IN), Tendon or ligament graft for promoting autogenous tissue growth.
Sachs Emanuel M. (Somerville) Haggerty John S. (Lincoln) Cima Michael J. (Lexington) Williams Paul A. (Concord MA), Three-dimensional printing techniques.
Knapp ; Jr. Peter M. (Indianapolis IN) Lingeman James E. (Indianapolis IN) Demeter Robert J. (Mooresville IN) Badylak Stephen F. (W. Lafayette IN), Tissue graft and method for urinary urothelium reconstruction replacement.
Badylak Stephen F. (West Lafayette IN) Geddes Leslie A. (West Lafayette IN) Lantz Gary (Lafayette IN) Coffey Arthur C. (Indianapolis IN), Tissue graft composition.
Badylak Stephen F. (West Lafayette IN) Geddes Leslie A. (West Lafayette IN) Lantz Gary (Lafayette IN) Coffey Arthur C. (Indianapolis IN), Tissue graft composition.
Badylak Steven F. (2610 Nottingham Pl. West Lafayette IN 47906) Demeter Robert J. (360 Cottonwood Dr. Mooresville IN 46158) Hiles Michael (3817 Cologne Ct. Indianapolis IN 46208) Voytik Sherry (271 S, Tissue graft for surgical reconstruction of a collagenous meniscus and method therefor.
Haslam John L. (Lawrence KS) Higuchi Takeru (Lawrence KS) Mlodozeniec Arthur R. (Lawrence KS), Topical drug delivery system utilizing thermosetting gels.
Allcock Harry R. (State College PA) Austin Paul E. (Williamstown WV) Kwon Sukky (University Park PA), Water-soluble phosphazene polymers having pharmacological applications.
Campbell, Phil G.; Burgess, James E.; Weiss, Lee E.; Smith, Jason, Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.